on 24 May 2022
Last Applicant/ Owned by
325 East Middlefield Road
Mountain View
CA
94043
Serial Number
88984103 filed on 21st Jun 2019
Registration Number
6740135 registered on 24th May 2022
Correspondent Address
Karen Feisthamel
Filing Basis
1. intent to use
2. filed as use application
3. use application currently
Disclaimer
NO DATA
Research and development services in the field of antibodies; providing information on the subject of scientific research in the field of biochemistry and biotechnology; providing medical research and scientific research information in the field of oncology; biotechnology research; research and development in the pharmaceutical and biotechnology fields Pharmaceutical preparations and substances f Read More
Research and development services in the field of antibodies; providing information on the subject of scientific research in the field of biochemistry and biotechnology; providing medical research and scientific research information in the field of oncology; biotechnology research; research and development in the pharmaceutical and biotechnology fields
30th Sep 2010
30th Sep 2010
Pharmaceutical preparations and substances for the treatment of viral, oncological, respiratory, and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of infectious diseases, pharmaceutical products for the treatment of viral and infectious diseases, and for the treatment of cancer
25th Sep 2020
25th Sep 2020
No 88984103
No Service Mark
No 8570.T0003
No
No
No
No
No
No
No
No
26.15.28 -
Miscellaneous designs with overall polygon shape
Status Date | Action Taken |
---|---|
25th May 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
24th May 2022 | REGISTERED-PRINCIPAL REGISTER |
20th Apr 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
19th Apr 2022 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
19th Apr 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
18th Apr 2022 | DIVISIONAL PROCESSING COMPLETE |
18th Apr 2022 | STATEMENT OF USE PROCESSING COMPLETE |
15th Apr 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
31st Mar 2022 | TEAS STATEMENT OF USE RECEIVED |
31st Mar 2022 | TEAS REQUEST TO DIVIDE RECEIVED |